Compass Pathways (CMPS) said Wednesday that its common stock will be added to the Nasdaq Biotechnology Index on Dec. 23 before market open.
The NBI tracks the performance of biotechnology and pharmaceutical companies listed on Nasdaq and is modified market capitalization weighted index.